Remissions in Myalgic Encephalomyelitis (M.E.)

Purpose

This page explains the nature of remission in Myalgic Encephalomyelitis (M.E.), including what remission means, what improves, what remains affected, and why remissions are often temporary. It also highlights factors that influence remission and relapse, and the implications for long-term management.

Key Points

1. Nature of Remission in M.E.

• Remission is usually not a full recovery
• It typically represents a temporary improvement in function, not a return to normal health
• Underlying biological abnormalities often remain active

2. What May Improve During Remission

• Reduced orthostatic intolerance (improved ability to be upright)
• Slight improvements in cognitive stamina
• Decreased pain (muscle and nerve-related)
• Fewer flu-like or systemic symptom episodes
• Improved tolerance to light, sound, and sensory input
• More stable cardiovascular and autonomic symptoms

3. What Does Not Fully Resolve

Even during remission, underlying dysfunction may persist, including:

• Impaired energy metabolism and oxygen use
• Abnormal cardiovascular and autonomic function
• Low blood volume
• Ongoing neuroinflammation
• Immune system abnormalities

Remission reflects reduced stress on the system, not full biological healing.

4. Factors That May Contribute to Remission

Remissions are often spontaneous but may be associated with:

• Reduced physiological stress (infection, inflammation, environmental factors)
• Treatment of secondary conditions (e.g. nutrient deficiencies, sleep disorders)
• Extended periods of rest
• Improved autonomic stability (hydration, salt, temperature control)
• Natural fluctuation of disease activity

5. Common Triggers for Relapse

Remissions are often fragile and can be disrupted by:

• Minor infections
• Physical or cognitive overexertion
• Emotional or physiological stress
• Temperature extremes
• Travel
• Medical procedures (e.g. surgery, anaesthesia)
• Hormonal changes
• Sleep disruption

Relapses may return symptoms to baseline severity or worsen them.

6. Rare Near-Recovery Cases

• A small number of patients, often early in illness, may experience near-normal function
• However:
  • Underlying vulnerability remains
  • Relapse is common over time
• Permanent recovery is considered rare

7. Remission Across Severity Levels

• Mild M.E.:
  • More likely to experience longer or more noticeable remissions
  • May temporarily function close to normal with strict pacing
• Moderate M.E.:
  • Remission may allow limited activity or part-time functioning
• Severe M.E.:
  • Improvements may include reduced symptoms or brief ability to sit upright
• Very Severe M.E.:
  • Remission typically means stabilization rather than functional improvement

8. Psychological and Emotional Impact

• Fear of losing improvement
• Pressure to return to normal activity
• Emotional distress when relapse occurs
• Difficulty managing pacing during improvement phases
• Cycles of hope and setback

Target Audience

This information is intended for:

• People living with M.E.
• Carers and family members
• Healthcare professionals
• Researchers and advocates

Overall Outcome

This page highlights that remission in M.E. is typically a temporary and partial improvement rather than full recovery. Understanding the nature of remission helps:

• Set realistic expectations
• Prevent overexertion during improvement
• Reduce risk of relapse
• Support safer, long-term management strategies

Key Summary Statement

Remission in M.E. represents a temporary reduction in symptom severity, not full recovery, with underlying biological dysfunction continuing and a high risk of relapse.